We must be getting closer to the initial market entry of Oraline.
Orasure (NASDAQ OSUR) is probably the closest comparison to SBN, and they are a large, successful listed company:
"Our business principally involves the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using our proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
